169201 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing; Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase with separation of immune complex from unbound antigen or antibody
Sub-classes:METHOD OF DETERMINING THE PRESENCE AND/OR AMOUNT OF TARGET MOLECULES
#2ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF
#3IMMUNE CELL SELECTION, EXPANSION, AND USE
#4p53 FRAGMENTS AS MARKERS FOR DIAGNOSIS AND PROGNOSIS OF NEURODEGENERATIVE DISEASE STATES
#5IDENTIFYING NON-DISEASE PATIENTS USING A DISEASE RELATED ASSAY AND ANALYSIS IN THE LIQUID BIOPSY
#6Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#7DEVICES, METHODS, AND KITS FOR ISOLATION AND DETECTION OF ANALYTES USING MICROSLIT FILTERS
#8INDIRECT HOMOGENEOUS MOBILITY SHIFT ASSAYS FOR THE DETECTION OF BIOLOGICS IN PATIENT SAMPLES
#9SINGLE-MOLECULE ELECTRONIC MULTIPLEX NANOPORE IMMUNOASSAYS FOR BIOMARKER DETECTION
#10DUAL BARCODE INDEXES FOR MULTIPLEX SEQUENCING OF ASSAY SAMPLES SCREENED WITH MULTIPLEX INSOLUTION PROTEIN ARRAY
#11Methods and Devices For Complexing Target Entities
#12Parallel flow cytometer using radiofrequency multiplexing
#13ANTIBODIES TO ALPHA-SYNUCLEIN AND USES THEREOF
#14Parallel flow cytometer using radiofrequency multiplexing
#15Controlled Exposure to Pathogens for Generating Immunity
#16Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation
#17Parallel flow cytometer using radiofrequency multiplexing
#18METHOD OF FABRICATING SUBSTRATE FOR ANALYSIS, SUBSTRATE FOR ANALYSIS, AND ANALYSIS UNIT
#19Analyte detection and methods therefor
#20METHOD FOR DETECTION OF CELLS BY REPETITIVE STAINING AND DESTAINING
#21Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection
#22Controlled Exposure to Pathogens for Generating Immunity
#23POLYMERIC DYES HAVING A BACKBONE COMPRISING ORGANOPHOSPHATE UNITS
#24Parallel flow cytometer using radiofrequency multiplexing
#25Target substance separation method and quantification method
#26METHOD OF DETERMINING THE PRESENCE AND/OR AMOUNT OF TARGET MOLECULES
#27METHOD OF TREATING PLASMA FOR USE
#28Antibodies to alpha-synuclein and uses thereof
#29Devices, methods, and kits for isolation and detection of analytes using microslit filters
#30METHOD FOR THE ISOLATION OF INTACT EXTRACELLULAR VESICLES
#31REVERSIBLE CELL LABELLING WITH CONJUGATES HAVING TWO RELEASABLE BINDING SITES
#32Rapid bacteria test
#33Methods and devices for complexing target entities
#34Method of screening antibody and antibody screening system using the same
#35Target Detection with Nanopore
#36Treatment and diagnosis of parkinson's disease using isolated and enriched populations of biofluid-derived extracellular vesicles
#37Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression
#38LTBP COMPLEX-SPECIFIC INHIBITORS OF TGF-BETA 1 AND USES THEREOF
#39Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#40Method of Selecting for Antibodies
#41Parallel flow cytometer using radiofrequency multiplexing
#42Ligand identification by co-fractionation
#43FUSION PROTEIN AND APPLICATIONS THEREOF
#44Phosphoprotein detection using a chip-based pillar array
#45Methods for detecting antibodies
#46Detection and identification of cell bound and soluble antigens using magnetic levitation
#47Antibodies to alpha-synuclein and uses thereof
#48MEMBRANE-BASED ANALYTICAL DEVICE FOR BODILY FLUIDS
#49Parallel flow cytometer using radiofrequency multiplexing
#50Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression
#51Cell detection method
#52Parallel flow cytometer using radiofrequency multiplexing
#53Rapid test for bacteria
#54Method of capturing exosomes
#55Method of determining the presence and/or amount of target molecules
#56Analyte detection and methods therefor
#57Phosphoprotein detection using a chip-based pillar array
#58Antibodies to α-synuclein and uses thereof
#59Indirect homogeneous mobility shift assays for the detection of biologics in patient samples
#60Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels
#61Method for measurement of vitamin D
#62Rapid test to determine the necessity of revaccination
#63LABEL-FREE DETECTION OF MACROMOLECULES BINDING TO COMPOUND LIBRARIES
#64Target detection with nanopore
#65Cell detection with conjugates having an enzymatically releasable detection moiety
#66Methods for detecting Aβ oligomers
#67Flow assay method for an object of interest
#68Methods for detecting antibodies
#69Detection of specific antigens in a population of antigens
#70Systems, devices, and methods for agglutination assays using sedimentation
#71Biosensor having decoupled capture chamber and detection chamber, using particle aggregation and size-separation
#72Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis
#73Microfluidic devices for the capture of biological sample components
#74Motor protein device
#75Cell-based methods for coupling protein interactions and binding molecule selection
#76Method and system for analyzing a blood sample
#77Method for performing a biochemical analysis, especially in outer space
#78MOBILITY SHIFT ASSAYS FOR DETECTING ANTI-TNF ALPHA DRUGS AND AUTOANTIBODIES THERETO
#79In vivo flow cytometry based on cellular autofluorescence
#80Flow cytometry analysis of materials adsorbed to metal salts
#81MOBILITY SHIFT ASSAYS FOR DETECTING ANTI-TNF ALPHA DRUGS AND AUTOANTIBODIES
#82Microfluidic devices for the capture of biological sample components
#83Receptor binding ligands, their use in the detection of cells with biological interest
#84General composition framework for ligand-controlled RNA regulatory systems
#85METHOD AND APPARATUS FOR DETECTING ANALYTES
#86Detection of specific antigens in a population of antigens
#87General composition framework for ligand-controlled RNA regulatory systems
#88Methods of signal generation and signal localization for improvement of signal readability in solid phase based bioassays
#89Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FCγRI receptor (CD64)
#90METHODS AND COMPOSITIONS FOR RISK STRATIFICATION
#91Methods for measuring concentrations of biomolecules
#92Methods and Compositions for Risk Stratification
#93Multiplex Cellular Assays Using Detectable Cell Barcodes
#94Methods and compositions for risk stratification
#95Methods and compositions for risk stratification
#96Methods for detecting antibodies
#97Method for quantification of antigen-specific canine IgE
#98Enhanced immunoassay sensor
#99In vivo flow cytometry based on cellular autofluorescence
#100Systems and methods for immunosorbent assays for single and multiple analytes
#101AFFINITY CONTROL OF TAGGING NOISE
#102Method and system for analyzing a blood sample
#103Methods and compositions for risk stratification
#104Detection of antigens carried by erythrocytes and of anti-erythrocyte antibodies
#105Multiple analysis of blood samples
#106METHOD OF ANALYZING CELLS BY FLOW CYTOMETRY, USE OF AN ANTIOXIDANT AND/OR FREE RADICAL-SCAVENGING AGENT IN SUCH A METHOD AND INCUBATION BUFFER COMPRISING AN ANTIOXIDANT AND/OR FREE RADICAL-SCAVENGING AGENT
#107Facs- and Reporter Protein-Based System for High Throughput Development of Therapeutic Proteins
#108Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels
#109Software integrated cytometric assay for quantification of the human polymorphonuclear leukocyte FcγRI receptor (CD64)
#110Methods and compositions for risk stratification
#111METHODS AND COMPOSITIONS FOR RISK STRATIFICATION
#112METHODS AND COMPOSITIONS FOR RISK STRATIFICATION
#113Multiplex cellular assays using detectable cell barcodes
#114Particle agglutination-evaluating container
#115Methods and compositions for risk stratification
#116Novel Classification Method of Blood Cells and Tailor-Made Therapy and Prevention Based Thereupon
#117Nanoporous membrane immunosensor
#118Cell separation compositions and methods
#119Pharmacodynamic assays
#120Apparatus and method for single-step immunosorbent assay for single and multiple analytes
#121A Method for the Separation Anti-Amyloid Beta Antibody with Amyloid Beta Peptide
#122Multiplex flow assays preferably with magnetic particles as solid phase
#123Multiplex flow assays preferably with magnetic particles as solid phase
#124Microchip-based system for hiv diagnostics
#125Method for determining the binding behavior of ligands which specifically bind to target molecules
#126Method and apparatus for detecting analyte with filter
#127Apparatus, kits and methods for evaluating binding interactions, for detecting and quantifying binding molecules, and for sample preparation
#128Multiplex flow assays preferably with magnetic particles as solid phase
#129Comprehensive food allergy test
#130Blood cell separating system
#131Multiplexed analysis of clinical specimens apparatus and methods
#132Methods and compositions for risk stratification
#133Method for characterizing and separating molecular associates
#134Gain of function sorting for drug discovery and development
#135Systems, devices, and methods for agglutination assays using sedimentation
#136Method and test strip for detecting residues